CLSD CLEARSIDE BIOMEDICAL INC Operational Disruptions 8-K Filing 2023 - Clinical Trial Announcement Clearside Biomedical announced plans for a Phase 2b clinical trial of CLS-AX for wet AMD, with enrollment starting in Q2 2023 and results expected in Q3 2024.Get access to all SEC 8-K filings of the CLEARSIDE BIOMEDICAL INC